Revenue Growth Driven by Top-Line Expansion
Revenue grew 7.4% YoY to $5.13B in Q1 2026 from $4.78B in Q1 2025, indicating continued demand for GEHC's medical imaging, ultrasound, and patient care solutions despite a challenging macro environment.
GE HealthCare Technologies Inc. is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: GE HealthCare reported Q1 2026 revenue of $5.13B (+7.4% YoY), but profitability deteriorated sharply with net income falling 31% to $389M, driven by gross margin compression of ~360 bps and a surge in investing cash outflows reflecting significant acquisition activity.
Drawn from management commentary in the Q1 2026 10-Q:
Revenue grew 7.4% YoY to $5.13B in Q1 2026 from $4.78B in Q1 2025, indicating continued demand for GEHC's medical imaging, ultrasound, and patient care solutions despite a challenging macro environment.
Gross margin declined approximately 360 basis points YoY to 38.5% from 42.1%, with gross profit falling $35M despite higher revenues, suggesting significant cost of goods sold inflation, unfavorable product mix, or tariff-related headwinds impacting manufacturing costs.
Operating income fell 18.1% to $515M and net income dropped 31.0% to $389M, with SG&A expenses rising 7.4% to $1.12B in line with revenue growth, while the steeper net income decline points to higher interest or other below-the-line costs associated with increased long-term debt.
Revenue
$5.13B
++7.41% YoY
EPS (Basic)
$0.85
-30.89% YoY
Gross Margin
38.5%
-3.59% YoY
Operating Income
$515M
-18.12% YoY
Add GEHC to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.